Exploring hospital volume thresholds for improved sarcoma treatment across different age categories in the United States
Exploring hospital volume thresholds for improved sarcoma treatment across different age categories in the United States is a paper indexed in PICO Portal from OpenAlex.
How many citations does Exploring hospital volume thresholds for improved sarcoma treatment across different age categories in the United States have?
Exploring hospital volume thresholds for improved sarcoma treatment across different age categories in the United States has 3 citations in the OpenAlex counts PICO Portal stores.
When was Exploring hospital volume thresholds for improved sarcoma treatment across different age categories in the United States published?
Exploring hospital volume thresholds for improved sarcoma treatment across different age categories in the United States has 2025 year in the PICO Portal index.
What is the open-access status of Exploring hospital volume thresholds for improved sarcoma treatment across different age categories in the United States?
Exploring hospital volume thresholds for improved sarcoma treatment across different age categories in the United States has green oa status in the PICO Portal index.
What is the DOI of Exploring hospital volume thresholds for improved sarcoma treatment across different age categories in the United States?
The DOI for Exploring hospital volume thresholds for improved sarcoma treatment across different age categories in the United States is on the source record.
What is the PMID of Exploring hospital volume thresholds for improved sarcoma treatment across different age categories in the United States?
The PMID for Exploring hospital volume thresholds for improved sarcoma treatment across different age categories in the United States is on the source record.
What is the OpenAlex record for Exploring hospital volume thresholds for improved sarcoma treatment across different age categories in the United States?
The OpenAlex for Exploring hospital volume thresholds for improved sarcoma treatment across different age categories in the United States is on the source record.